Transcatheter Tricuspid Valve Treatment: A Growing Armamentarium of Devices
Abstract Tricuspid regurgitation is a frequent and undertreated condition associated with poor outcomes. Over the past decade, transcatheter tricuspid valve interventions have emerged as a valuable alternative for high-risk patients. Edge-to-edge repair is the most widely adopted approach, while replacement technologies are advancing rapidly and offer the potential for near-complete elimination of regurgitation. In parallel, annuloplasty, spacers, and caval devices are broadening the therapeutic spectrum across diverse anatomies. This review outlines the expanding device armamentarium and the key opportunities and challenges in this evolving field.
Authors
- Henryk Dreger (ORCID: https://orcid.org/0000-0003-1909-4329)
- Xavier Freixa (ORCID: https://orcid.org/0000-0002-3203-9060)
- Julio Echarte‐Morales (ORCID: https://orcid.org/0000-0003-3951-6875)
- Nicole Karam
- Philip Lurz
- Thomas Modine
- Axel Linke
- Rodrigo Estevez-Loureiro
Institutions
- Johannes Gutenberg University Mainz (DE)
- University Hospital Complex Of Vigo (ES)
- Humboldt-Universität zu Berlin (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Deutsches Herzzentrum der Charité (DE)
- Hospital Clínic de Barcelona (ES)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- Hôpital Georges-Clemenceau (FR)
- Klinik und Poliklinik für Psychotherapie und Psychosomatik (DE)
Publication Details
- Journal
- European Heart Journal Supplements
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1093/eurheartjsupp/suaf098
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00